Vicencio, JM; Evans, R; Green, R; An, Z; Deng, J; Treacy, C; Mustapha, R; ... Ng, T; + view all (2022) Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans. Cell Death & Disease , 13 (3) , Article 274. 10.1038/s41419-022-04701-3. Green open access